Generation Bio Co.
GBIO
$0.3712
-$0.0375-9.18%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 4.19M | 7.55M | 4.09M | 4.06M | 2.88M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.19M | 7.55M | 4.09M | 4.06M | 2.88M |
| Cost of Revenue | 12.20M | 11.86M | 12.91M | 10.80M | 21.57M |
| Gross Profit | -8.01M | -4.30M | -8.82M | -6.75M | -18.69M |
| SG&A Expenses | 12.33M | 12.41M | 12.89M | 13.96M | 19.73M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 24.53M | 24.27M | 25.80M | 24.76M | 41.30M |
| Operating Income | -20.34M | -16.72M | -21.71M | -20.70M | -38.42M |
| Income Before Tax | -21.38M | -15.31M | -20.43M | -74.54M | -35.19M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -21.38M | -15.31M | -20.43M | -74.54M | -35.19M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -21.38M | -15.31M | -20.43M | -74.54M | -35.19M |
| EBIT | -20.34M | -16.72M | -21.71M | -20.70M | -38.42M |
| EBITDA | -19.17M | -15.54M | -20.45M | -19.39M | -37.10M |
| EPS Basic | -0.32 | -0.23 | -0.31 | -1.12 | -0.53 |
| Normalized Basic EPS | -0.17 | -0.13 | -0.18 | -0.17 | -0.33 |
| EPS Diluted | -0.32 | -0.23 | -0.31 | -1.12 | -0.53 |
| Normalized Diluted EPS | -0.17 | -0.13 | -0.18 | -0.17 | -0.33 |
| Average Basic Shares Outstanding | 66.79M | 66.74M | 66.53M | 66.43M | 66.06M |
| Average Diluted Shares Outstanding | 66.79M | 66.74M | 66.53M | 66.43M | 66.06M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |